tiprankstipranks
Trending News
More News >
Rohto Pharmaceutical Co (JP:4527)
OTHER OTC:4527

Rohto Pharmaceutical Co (4527) Revenue

Compare
1 Followers

Rohto Pharmaceutical Co Revenue

Rohto Pharmaceutical Co had a revenue of 81.96B in the quarter ending Jun 30, 2025, with -0.93%. This bring the company's revenue in the last twelve months to 322.23B, Decreased 4.41%. In the fiscal year ending Dec 31, 2025, Rohto Pharmaceutical Co had annual revenue of 308.63B with 13.95% growth.
Revenue (ttm)
322.23B
Revenue Growth
18.35%
P/S Ratio
1.94
Revenue/Employee
¥42,516,187
Employees
7,259
Market Cap
¥598.27B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
308.63B37.78B+113.95%
Dec 31, 2024
270.84B32.18B+113.48%
Dec 31, 2023
238.66B39.02B+119.54%
Dec 31, 2022
199.65B18.59B+110.27%
Dec 31, 2021
181.05B-7.32B+96.11%
Dec 31, 2020
188.38B4.70B+102.56%
Dec 31, 2018
183.67B11.88B+106.91%
Dec 31, 2017
171.79B17.20B+111.12%
Dec 31, 2016
154.60B